Discovery and in vitro characterization of a human anti-CD36 scFv
IntroductionCD36 is a membrane receptor that participates in the cellular uptake of fatty acids and lipid metabolism. CD36 overexpression favors progression of different pathologies, such as atherosclerosis and cancer. Thus, CD36 targeting has medicinal relevance. Herein, we aimed to identify human...
Saved in:
Main Authors: | Cecilia Mata-Cruz, Sandra L. Guerrero-Rodríguez, Keyla Gómez-Castellano, Gregorio Carballo-Uicab, Juan Carlos Almagro, S. Mayra Pérez-Tapia, Marco A. Velasco-Velázquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1531171/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
scFv Antibody: Principles and Clinical Application
by: Zuhaida Asra Ahmad, et al.
Published: (2012-01-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01) -
Simplified MS2 phage-like particle production including a novel maturation protein internal fusion affinity tag
by: Enos C. Kline, et al.
Published: (2025-12-01) -
The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective
by: Onder Onen, et al.
Published: (2020-12-01)